Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Just Biotherapeutics

Just Biotherapeutics
2014 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
M&A LATEST DEAL TYPE
$90M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of biotherapeutic technologies intended to dramatically expand global access to biotherapeutics. The company's offerings including integrating highly synergistic scientific expertise and machine learning driven technologies for design, development and manufacturing of biologics, providing clients with integrated designs that will accelerate development of biotherapeutics and substantially reduce their manufacturing cost.

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • South Lake Union
  • 401 Terry Avenue North
  • Seattle, WA 98109
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Just Biotherapeutics’s full profile, request a free trial.

Just Biotherapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Jul-2019 $90M 0000 0000 Completed Generating Revenue
3. Early Stage VC (Series A2) 25-Jul-2016 0000 0000 0000 Completed Startup
2. Grant 06-Nov-2015 $9.4M $15M Completed Startup
1. Early Stage VC (Series A) 18-Sep-2015 $15M $15M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Just Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A2 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 000
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
To view this company’s complete Cap Table, request access »

Just Biotherapeutics Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MediGene Corporate Backed or Acquired Planegg, Germany 000 00000 000000000 00000
00000 0000 0000 Venture Capital-Backed Pittsburgh, PA 0 00.000 0000000000 0 00.000
00000 000 Venture Capital-Backed South San Francisco, CA 0000 00000000000 0000
000000000 00000000 Corporate Backed or Acquired San Diego, CA 000 000000&0
00 00000000000 Formerly PE-Backed Shanghai, China 000000000000
To view this company’s complete list of competitors, request access »

Just Biotherapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Heda Ventures Venture Capital Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Bank of China Corporation Minority 000 0000 000000 0
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Just Biotherapeutics Executive Team (9)

Name Title Board
Seat
Contact
Info
James Thomas Ph.D Co-Founding Partner, Chief Executive Officer & Board Member
Victor Fung Co-Founding Partner, Chief Operating Officer & Board Member
Dean Pettit Ph.D Co-Founding Partner & Chief Scientific Officer
Carolina Rizo Ph.D Chief Business Officer
Vasant Gandhi Ph.D Vice President, Corporate Development

4 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

Just Biotherapeutics Board Members (6)

Name Representing Role Since Contact
Info
Charles Cooney Ph.D Self Board Member 000 0000
James Thomas Ph.D Just Biotherapeutics Co-Founding Partner, Chief Executive Officer & Board Member 000 0000
Jimmy Zhang Lilly Asia Ventures Board Member 000 0000
Steven Gillis Ph.D ARCH Venture Partners Board Member 000 0000
Victor Fung Just Biotherapeutics Co-Founding Partner, Chief Operating Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »